9th International Caparica Conference on Analytical Proteomics 2024

23rd to 27th June 2024 | Caparica | Portugal

Focus in precision biochemistry and precision medicine

Dear Colleagues and friends

On behalf of the organizing committee, we are delighted to welcome you to Caparica (Lisbon, Portugal) for the 9th International Congress on Analytical Proteomics – ICAP 2024.

The Congress will take place in Costa de Caparica the 23rd to 27th June 2024.

We warmly encourage you to attend and contribute to one of the major events in 2024 in the Proteomics field. We are confident that you will appreciate the breadth and quality of the scientific program and the city of Caparica and look forward to seeing you in 2024 in Portugal.

Yours truly,

J. L. Capelo

C. Lodeiro

H.M. Santos

Conference chairs

On behalf of the organizing and scientific committee

Plenary Speakers

Jiri Adamec, PhD

Stanley S. Scott Cancer Center, Department of Interdisciplinary Oncology, New Orleans (USA)

Health Disparities and Affordable Precision Medicine

Renã A.S. Robinson, PhD

Department of Chemistry, Vanderbilt University, Nashville (USA)

Proteomics advances in aging and Alzheimer’s disease

Steven A. Carr, PhD

Senior Director of Proteomics and Institute Scientist, Broad Institute of MIT and Harvard, Cambridge (USA)

Quantitative proteomics in Biology and Clinical Medicine

Mamuka Kvaratskhelia, PhD

University of Colorado School of Medicine. Colorado (USA)

Ellen D. McPhail, PhD

Department of Laboratory Medicine and Pathology Tissue Proteomics Clinical Laboratory Mayo Clinic, Rochester (USA)

Proteomics-based classification of membranous nephropathy

Nataly Kravchenko-Balasha, PhD

The Institute of Biomedical and Oral Research, The Hebrew University of Jerusalem, Jerusalem (Israel)

Daniel Martins-de-Souza, PhD

University of Campinas – Unicamp, Campinas (Brazil)

Employing neuroproteomics to decipher the molecular underpinnings of Schizophrenia

Jean Pieters, PhD

Biozentrum, University of Basel, Basel (Switzerland)

Cell population size control by coronin proteins

Julio Chirinos, PhD

Hospital of the University of Pennsylvania, Philadelphia (USA)

Deciphering Human Heart Failure with Proteomics Approaches: A focus on risk stratification and underlying biology

Pierre-Olivier Schmit, PhD

Bruker

4D proteomics : addressing the challenges of clinical proteomics research

KPRK Talks

Lilian Kato, PhD

University of Campinas – Unicamp, Campinas (Brazil)

Multimodal Speciomics techniques based on HPLC simultaneously coupled to ICP-MS/MS and ESI-HRMS to identify biomolecules containing heteroatoms and novel species

Keynote Speakers

Nelson Soares, PhD

Department of Medicinal Chemistry, University of Sharjah, Sharjah (UAE)

Jerry Morrisey, PhD

Department of Anesthesiology, Washington University School of Medicine, St. Louis (USA)

High-resolution imaging of protein secretion at the single-cell level using plasmon-enhanced FluoroDOT assay

Sanjiv Dhingra, PhD

Department of Physiology and Pathophysiology, University of Manitoba, Winnipeg (USA)

Multi-Omics approaches for cardiac regeneration and cardio-immunology

Yuichi J. Shimada, PhD

Columbia University Medical Center, Columbia (USA)

Application of Proteomics Profiling to Predict Cardiac Events in Patients with Hypertrophic Cardiomyopathy

Liviu Movileanu, PhD

Syracuse University, Syracuse (USA)

Bioinpired Nanopore Sensors Using Antibody Mimetic Technologies

Thomas Helikar, PhD

University of Nebraska-Lincoln (USA)

Towards Immune Digital Twins: The Need for New Data-Generation Strategies

Qing Li, PhD

University of Hawaii at Manoa (USA)

Glycogen synthase kinase 3β substrate competitive inhibitors alleviate Alzheimer’s disease related hallmarks

Sonia Sharma, PhD

La Jolla Institute For Immunology (USA)

Advanced rapid liquid chromatography mass spectrometry (rLC-MS) metabolomics identifies bio-active lipid metabolite modulators of clinical cancer immunotherapy outcomes

Taicia Pacheco Fill, PhD

University of Campinas – Unicamp, Campinas (Brazil)

Microbial villains in Brazilian citriculture: What do we know and how can we protect our orchards?

Michele Mishto, PhD

King’s College London (UK)

Rune Matthiesen, PhD

NOVA Medical School (Portugal)

Profiling of urinary extracellular vesicle protein signatures from patients with cribriform and intraductal prostate carcinoma in a cross-sectional study

Luigi Puglielli, PhD

University of Wisconsin-Madison (USA)

ER acetylation and proteostasis

Julian Liepe, PhD

Max-Planck-Institute for Multidisciplinary Sciences (Germany)

Tackling the Large Search Space Problem in Proteomics and Immunopeptidomics

Kong-Joo Lee, PhD

Ewha Womans University (South Korea)

Redox Proteomics in Cancer metastasis and Depression model

Hugo M. Santos, PhD

NOVA University of Lisbon (Portugal)

Seong-Yong Seong, PhD

Seoul National University College of Medicine (South Korea)

Symposium Subjects

  • Array-based analytical proteomics
  • Cardiovascular proteome biology
  • Computational approaches to mine proteomic data
  • Innovation in peptide & protein separation technologies
  • Metabolomics
  • Molecular mass imaging & single cell imaging
  • Proteome biology of infectious diseases
  • Quantitative Proteomics
  • Renal and urinary proteomics
  • Stem cell proteome biology
  • Biomarker discovery & validation
  • Chemical proteomics
  • Glycoproteomics & phosphoproteomics
  • Mass spectrometry innovations
  • Metallomics
  • Organelle and biological membranes proteomics
  • Proteomics of macromolecular complexes
  • Structural proteomics

Hotel TRYP Lisboa Caparica Mar

Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of ICAP 2024 is working with CHS

We look forward to seeing you soon.

With kindest regards

The BIOSCOPE Team